Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 23.5 AMA PRA Category 1 CreditsTM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Commercial Supporters

This activity is supported by educational grants from Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, and Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

13th Annual International Lung Cancer Congress®

13th Annual International Lung Cancer Congress®


Day 1 | Day 2 | Day 3 | Day 4

Day 1  
State of the Art: Early-Stage Non-small Cell Lung Cancer (NSCLC) Moderator: David Gandara, MD
Keynote: Update for 2012 on CT Screening for Early Detection of Lung Cancer Denise Aberle, MD
Optimal Application of Adjuvant Therapy in NSCLC Barbara Gitlitz, MD
Optimizing NSCLC Staging: EBUS vs. Mediastinoscopy
Endobronchial Ultrasound Henri Colt, MD
Mediastinoscopy Stephen Swisher, MD
Surgical Resection vs. SBRT in Patients with NSCLC and Poor Pulmonary Function
Surgical Resection David Jablons, MD
Stereotactic Body Radiotherapy Walter Curran, MD
Role of the Pulmonologist in Diagnosis and Treatment Selection for Lung Cancer Ken Yoneda, MD
Panel Discussion:
Impact and Application of the IASLC Staging Project
Chair: Kemp Kernstine, MD
Panel: Denise Aberle, MD; Walter Curran, MD; Barbara Gitlitz, MD; David Jablons, MD; Stephen Swisher, MD; Ignacio Wistuba, MD; Ken Yoneda, MD, Henri Colt, MD
State-of-the-Art in Combined Modality Therapy for NSCLC Moderator: Sue Yom, MD
State-of-the-Art: Multimodality Therapy Everett Vokes, MD
Surgical Approaches to Locally Advanced NSCLC Kemp Kernstine, MD, PhD
Optimizing the Dose and Schedule of Radiation Therapy in Stage III NSCLC Walter Curran, MD
Innovations in Radiation Therapy, Including SBRT, IMRT, and Proton Beam Therapy Sue Yom, MD
Integration of Targeted Agents Into Combined Modality Therapy for NSCLC Corey Langer, MD
Case-Based Panel Discussion: Combined Modality Therapy Chair: Sue Yom, MD
Panel: Walter Curran, MD; Corey Langer, MD; Kemp Kernstine, MD, PhD; Ignacio Wistuba, MD; Everett Vokes, MD
Poster Discussant 1 Corey Langer, MD
Workshop 1: Multidisciplinary Tumor Board Moderator: Kemp Kernstine, MD, PhD
1. Surgical Case
2. Radiation Therapy Case
3. Pulmonary Case
4. Standard of Care Case
Henri Colt, MD; Laurie Gaspar, MD; Barbara Gitlitz,MD; Karen Reckamp, MD; Stephen Swisher, MD; Sue Yom, MD; Ken Yoneda, MD
 
Day 2  
State-of-the-Art Treatment of Advanced Lung Cancer Moderator: Primo N. Lara, Jr, MD
Keynote: State-of-the-Art: Advanced Lung Cancer Paul Bunn, MD
ALK Inhibitors Tina Li, MD, PhD
c-Met Inhibitors David Gandara, MD
Novel Cytotoxics in Metastatic NSCLC Suresh Ramalingam, MD
Immunotherapy in Lung Cancer Roy Herbst, MD, PhD
Incorporating Next Generation Sequencing for Molecular Profiling: Future Implications for Treatment Phillip Mack, MD
Case Based Panel Discussion:
Advanced NSCLC
Chair: Primo N. Lara, Jr, MD
Panel: Paul Bunn, MD; Tina Li, MD, PhD; Suresh Ramalingam, MD; Joan Schiller, MD
Fifth Annual Addario Foundation Keynote Lecture
Rediscovering Lung Cancer Ross Camidge, MD, PhD
Personalized Medicine for Mesothelioma and SCLC Moderator: Primo N. Lara, Jr, MD
Mesothelioma: State of the Art Paul Baas, MD, PhD
Current Approaches for LD-SCLC Laurie Gaspar, MD
How I Treat: ED-SCLC Primo N. Lara, Jr, MD
Panel Discussion:
Personalized Medicine for Mesothelioma and SCLC
Chair: Primo N. Lara, Jr, MD
Panel: Lyudmila Bazhenova, MD; Paul Baas, MD, PhD; Paul Bunn, MD; Laurie Gaspar, MD
Poster Discussant 2 Heather Wakelee, MD
Workshop 2: The Next Generation of Agents for Lung Cancer Moderator: Roy Herbst, MD, PhD
Targeting the PI3K/AKT Axis: What Lies Ahead in Lung Cancer Roy Herbst, MD, PhD
New Approaches for Antiangiogenic Therapy Alan Sandler, MD
Approaches to Inhibiting bFGFR Paul Bunn, MD
PARP Inhibitors in Lung Cancer Primo N. Lara, Jr, MD
Heat Shock Proteins as an Emerging Therapeutic Target Giorgio Scagliotti, MD
Reversing Resistance to EGFR TKIs Fred Hirsch, MD, PhD
MEK Inhibition: What Progress Have We Made? Karen Reckamp, MD
Panel Discussion Roy Herbst, MD, PhD; Alan Sandler, MD; Paul Bunn, MD; Primo N. Lara, Jr, MD; Giorgio Scagliotti, MD; Fred Hirsch, MD, PhD; Karen Reckamp, MD
Day 3
Maintenance and Second-line Therapy in Advanced NSCLC
Maintenance Therapy for Lung Cancer Debate
Moderator: Glenwood Goss, MD
Pro Heather Wakelee, MD
Con Glenwood Goss, MD
Approaches to Therapy of Metastatic NSCLC: Second-line and Beyond Alan Sandler, MD
Case-Based Panel Discussion:
Maintenance Therapy and Beyond
Chair: Glenwood Goss, MD
Panel: Heather Wakelee, MD; Corey Langer, MD; Alan Sandler, MD
Cooperative Group Update-“ A Rose By Any Other name?” Moderator: Walter Curran, MD
SPORE Update Fred Hirsch, MD
Europe Paul Baas, MD, PhD
Japan Masahiro Tsuboi, MD, PhD
SWOG David Gandara, MD
RTOG Walter Curran, MD
NCI-Canada Glenwood Goss, MD
ECOG Suresh Ramalingam, MD
CALGB Lyudmila Bazhenova, MD
ACOSOG Kemp Kernstine, MD, PhD
Panel Discussion  
   
Day 4  
Personalized Medicine for NSCLC Moderator: David Gandara, MD
Keynote: Individualized Therapy in Lung Cancer: Where Are We in 2011? Giorgio Scagliotti, MD
Biomarkers for Personalized Lung Cancer Therapy Fred Hirsch, MD, PhD
The Role of Pathology/Molecular Diagnostics in Personalized Medicine Ignacio Wistuba, MD
Personalized Medicine for Advanced NSCLC in East Asia Masahiro Tsuboi, MD
Optimizing Care for Special Populations in Lung Cancer (Women, Elderly, PS2) Corey Langer, MD
Case-Based Panel Discussion:
Personalized Medicine
Chair: David Gandara, MD
Panel: Giorgio Scagliotti, MD; Fred Hirsch, MD, PhD; Ignacio Wistuba, MD; Masahiro Tsuboi, MD; Corey Langer, MD

Day 1 | Day 2 | Day 3 | Day 4






Become a Member

Forgot Password?
Filter By